These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

689 related items for PubMed ID: 1346939

  • 1. Rationale for maintenance pharmacotherapy of opiate dependence.
    Kreek MJ.
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():205-30. PubMed ID: 1346939
    [Abstract] [Full Text] [Related]

  • 2. Neurobiology of addictive behaviors and its relationship to methadone maintenance.
    Stimmel B, Kreek MJ.
    Mt Sinai J Med; 2000; 67(5-6):375-80. PubMed ID: 11064487
    [Abstract] [Full Text] [Related]

  • 3. Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.
    Gold MS.
    Psychiatr Clin North Am; 1993 Mar; 16(1):61-73. PubMed ID: 8456048
    [Abstract] [Full Text] [Related]

  • 4. Current pharmacotherapies for opioid dependence.
    Kosten TR.
    Psychopharmacol Bull; 1990 Mar; 26(1):69-74. PubMed ID: 2196628
    [Abstract] [Full Text] [Related]

  • 5. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments.
    Kreek MJ, Bart G, Lilly C, LaForge KS, Nielsen DA.
    Pharmacol Rev; 2005 Mar; 57(1):1-26. PubMed ID: 15734726
    [Abstract] [Full Text] [Related]

  • 6. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Mar; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 7. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.
    Donny EC, Brasser SM, Bigelow GE, Stitzer ML, Walsh SL.
    Addiction; 2005 Oct; 100(10):1496-509. PubMed ID: 16185211
    [Abstract] [Full Text] [Related]

  • 8. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
    Kastelic A, Dubajic G, Strbad E.
    Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
    [Abstract] [Full Text] [Related]

  • 9. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S, Kemmler G, Ertl M, Riemer Y.
    Subst Use Misuse; 2006 Nov; 41(2):223-44. PubMed ID: 16393744
    [Abstract] [Full Text] [Related]

  • 10. Methadone and naltrexone in the treatment of heroin dependence.
    Greenstein RA, Resnick RB, Resnick E.
    Psychiatr Clin North Am; 1984 Dec; 7(4):671-9. PubMed ID: 6522309
    [Abstract] [Full Text] [Related]

  • 11. 24-Hour opiate detoxification and antagonist induction at home--the 'Asturian method': a report on 1368 procedures.
    Carreño JE, Bobes J, Brewer C, Alvarez CE, San Narciso GI, Bascarán MT, Sánchez del Río J.
    Addict Biol; 2002 Apr; 7(2):243-50. PubMed ID: 12006220
    [Abstract] [Full Text] [Related]

  • 12. Medical mismanagement in public methadone programs.
    Blansfield HN.
    Conn Med; 1994 Mar; 58(3):161-4. PubMed ID: 8039380
    [No Abstract] [Full Text] [Related]

  • 13. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT, Tait RJ, Hulse GK.
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [Abstract] [Full Text] [Related]

  • 14. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A, Parrino M, Schnoll SH, Fong C, Maxwell C, Cleland CM, Magura S, Haddox JD.
    Drug Alcohol Depend; 2007 Sep 06; 90(1):64-71. PubMed ID: 17386981
    [Abstract] [Full Text] [Related]

  • 15. [Pharmaco-clinical aspects of methadone. Literature review of its importance in treatment of substance dependence].
    Fontaine P, Ansseau M.
    Encephale; 1995 Sep 06; 21(3):167-79. PubMed ID: 7649067
    [Abstract] [Full Text] [Related]

  • 16. Outpatient opiate detoxification with clonidine.
    Washton AM, Resnick RB.
    J Clin Psychiatry; 1982 Jun 06; 43(6 Pt 2):39-41. PubMed ID: 7085584
    [Abstract] [Full Text] [Related]

  • 17. Differential regional effects of methadone maintenance compared to heroin dependence on mu-opioid receptor desensitization in rat brain.
    Martin TJ, Kahn WR, Xiao R, Childers SR.
    Synapse; 2007 Mar 06; 61(3):176-84. PubMed ID: 17152089
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users.
    Shi J, Zhao LY, Copersino ML, Fang YX, Chen Y, Tian J, Deng Y, Shuai Y, Jin J, Lu L.
    Eur J Pharmacol; 2008 Jan 28; 579(1-3):160-6. PubMed ID: 17977528
    [Abstract] [Full Text] [Related]

  • 20. Methadone maintenance treatment (MMT): a review of historical and clinical issues.
    Joseph H, Stancliff S, Langrod J.
    Mt Sinai J Med; 2000 Jan 28; 67(5-6):347-64. PubMed ID: 11064485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.